Cambridge Textbook of Neuroscience for Psychiatrists (eBook, ePUB)
Redaktion: Lynall, Mary-Ellen; Stahl, Stephen M.; Jones, Peter B.
68,95 €
68,95 €
inkl. MwSt.
Sofort per Download lieferbar
34 °P sammeln
68,95 €
Als Download kaufen
68,95 €
inkl. MwSt.
Sofort per Download lieferbar
34 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
68,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
34 °P sammeln
Cambridge Textbook of Neuroscience for Psychiatrists (eBook, ePUB)
Redaktion: Lynall, Mary-Ellen; Stahl, Stephen M.; Jones, Peter B.
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 75.5MB
Produktdetails
- Verlag: Cambridge University Press
- Erscheinungstermin: 16. November 2023
- Englisch
- ISBN-13: 9781009463669
- Artikelnr.: 70913282
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
I. Cells: 1.1. Neurons
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.
I. Cells: 1.1. Neurons
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.